Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT02445807

Public ClinicalTrials.gov record NCT02445807. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days

Study identification

NCT ID
NCT02445807
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Promius Pharma, LLC
Industry
Enrollment
265 participants

Conditions and interventions

Interventions

  • DFD06-Cream Drug
  • Vehicle Cream Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Jun 30, 2016
Completion
Jun 30, 2016
Last update posted
May 14, 2018

2015 – 2016

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Site 101 Birmingham Alabama 35205
Site 103 Mobile Alabama 36608
Site 130 Mesa Arizona 85202
Site 116 Phoenix Arizona 85251
Site 125 Tucson Arizona 85712
Site 120 North Hollywood California 91606
Site 114 San Diego California 92117
Site 127 Santa Monica California 90404
Site 128 Clearwater Florida 33756
Site 115 Miami Florida 33144
Site 118 Indianapolis Indiana 46256
Site 110 Louisville Kentucky 40202
Site 105 Glenn Dale Maryland 20769
Site 111 Warren Michigan 48088
Site 113 Fridley Minnesota 55432
Site 123 Saint Joseph Missouri 64506
Site 106 Newington New Hampshire 03801
Site 104 Albuquerque New Mexico 87106
Site 117 Stony Brook New York 11790
Site 124 High Point North Carolina 27262
Site 109 Winston-Salem North Carolina 27157
Site 129 Johnston Rhode Island 02919
Site 119 Anderson South Carolina 29621
Site 102 Greenville South Carolina 29607
Site 108 Austin Texas 78759
Site 122 Houston Texas 77030
Site 107 Plano Texas 75024
Site 112 Draper Utah 84020
Site 126 Spokane Washington 99202
Site 121 Walla Walla Washington 99362

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02445807, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02445807 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →